Global Pharmaceutical Dissolution Testing Services Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

Description

List of Tables

The global demand for Pharmaceutical Dissolution Testing Services Market is presumed to reach the market size of nearly USD 1574.95 MN by 2030 from USD 677.53 MN in 2022 with a CAGR of 11.12% under the study period 2023 - 2030.

Pharmaceutical dissolution testing refers to the test used in the pharmaceutical industry to assess the physical changes in an active pharmaceutical drug. It assists in determining the bioavailability and therapeutic effectiveness of all solid and semi-solid oral dosages. Pharmaceutical products are developed on the basis of these drug dissolution tests. It is used as a quality control tool for monitoring the drug released from the substance. Drug dissolution test helps in determining the pace with which the medications go into different areas of the body and the time they take to dissolve.

Market Dynamics:

The pharmaceutical dissolution testing services market is anticipated to scale up due to the development of various drugs for different chronic conditions. The rise in the cases of Type 2 diabetes is contributing to the growth of the pharmaceutical dissolution testing service market. Moreover, the increasing number of clinical studies and drugs approval is surging the demand for this market. Growth in the number of innovative drugs entering the preclinical stage of development is propelling the demand for this market. Furthermore, the rise in pharmaceutical research efforts coupled with large corporations' rising interest and increasing spending for research and development in this area is expected to boost the growth of this market in the upcoming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of pharmaceutical dissolution testing services. The growth and trends of pharmaceutical dissolution testing services industry provide a holistic approach to this study.

Market Segmentation:

This section of the pharmaceutical dissolution testing services market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Method

In Vitro
In Vivo

By Dosage Form

Capsules
Tablets
Others

By Dissolution Apparatus

Basket
Paddle
Others

Regional Analysis:

This section covers the regional outlook, which accentuates current and future demand for the Pharmaceutical Dissolution Testing Services market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the pharmaceutical dissolution testing services market include Intertek Group Plc., Avivia BV, Almac Group, Agilent Technologies Inc., Catalent Inc., Thermofisher Scientific Inc., Cambrex Corp, Charles River Laboratories, Boston Analytical, Pace Analytical Life Sciences, Sotax, Amri, SGS SA. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Product Code: VMR112110342

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . PHARMACEUTICAL DISSOLUTION TESTING SERVICES - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Method
- 3.7.2 Market Attractiveness Analysis By Dosage Form
- 3.7.3 Market Attractiveness Analysis By Dissolution Apparatus
- 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL PHARMACEUTICAL DISSOLUTION TESTING SERVICES MARKET ANALYSIS BY METHOD

6.1 Overview by Method
6.2 Historical and Forecast Data
6.3 Analysis by Method
6.4 In Vitro Historic and Forecast Sales by Regions
6.5 In Vivo Historic and Forecast Sales by Regions

7 . GLOBAL PHARMACEUTICAL DISSOLUTION TESTING SERVICES MARKET ANALYSIS BY DOSAGE FORM

7.1 Overview by Dosage Form
7.2 Historical and Forecast Data
7.3 Analysis by Dosage Form
7.4 Capsules Historic and Forecast Sales by Regions
7.5 Tablets Historic and Forecast Sales by Regions
7.6 Others Historic and Forecast Sales by Regions

8 . GLOBAL PHARMACEUTICAL DISSOLUTION TESTING SERVICES MARKET SALES ANALYSIS BY DISSOLUTION APPARATUS

8.1 Overview by Dissolution Apparatus
8.2 Historical and Forecast Data
8.3 Analysis by Dissolution Apparatus
8.4 Basket Historic and Forecast Sales by Regions
8.5 Paddle Historic and Forecast Sales by Regions
8.6 Others Historic and Forecast Sales by Regions

9 . GLOBAL PHARMACEUTICAL DISSOLUTION TESTING SERVICES MARKET SALES ANALYSIS BY GEOGRAPHY

9.1. Regional Outlook Sales Analysis
9.2. Introduction Sales Analysis
9.3. North America Sales Analysis
- 9.3.1. Overview, Historic and Forecast Sales Analysis
- 9.3.2. North America By Segment Sales Analysis
- 9.3.3. North America By Country Sales Analysis
- 9.3.4. United State Sales Analysis
- 9.3.5. Canada Sales Analysis
- 9.3.6. Mexico Sales Analysis
9.4. Europe Sales Analysis
- 9.4.1. Overview, Historic and Forecast Sales Analysis
- 9.4.2. Europe by Segment Sales Analysis
- 9.4.3. Europe by Country Sales Analysis
- 9.4.4. United Kingdom Sales Analysis
- 9.4.5. France Sales Analysis
- 9.4.6. Germany Sales Analysis
- 9.4.7. Italy Sales Analysis
- 9.4.8. Russia Sales Analysis
- 9.4.9. Rest Of Europe Sales Analysis
9.5. Asia Pacific Sales Analysis
- 9.5.1. Overview, Historic and Forecast Sales Analysis
- 9.5.2. Asia Pacific by Segment Sales Analysis
- 9.5.3. Asia Pacific by Country Sales Analysis
- 9.5.4. China Sales Analysis
- 9.5.5. India Sales Analysis
- 9.5.6. Japan Sales Analysis
- 9.5.7. South Korea Sales Analysis
- 9.5.8. Australia Sales Analysis
- 9.5.9. Rest Of Asia Pacific Sales Analysis
9.6. Latin America Sales Analysis
- 9.6.1. Overview, Historic and Forecast Sales Analysis
- 9.6.2. Latin America by Segment Sales Analysis
- 9.6.3. Latin America by Country Sales Analysis
- 9.6.4. Brazil Sales Analysis
- 9.6.5. Argentina Sales Analysis
- 9.6.6. Peru Sales Analysis
- 9.6.7. Chile Sales Analysis
- 9.6.8. Rest of Latin America Sales Analysis
9.7. Middle East & Africa Sales Analysis
- 9.7.1. Overview, Historic and Forecast Sales Analysis
- 9.7.2. Middle East & Africa by Segment Sales Analysis
- 9.7.3. Middle East & Africa by Country Sales Analysis
- 9.7.4. Saudi Arabia Sales Analysis
- 9.7.5. UAE Sales Analysis
- 9.7.6. Israel Sales Analysis
- 9.7.7. South Africa Sales Analysis
- 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE PHARMACEUTICAL DISSOLUTION TESTING SERVICES COMPANIES

10.1. Pharmaceutical Dissolution Testing Services Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments

11 . COMPANY PROFILES OF PHARMACEUTICAL DISSOLUTION TESTING SERVICES INDUSTRY

11.1. Top 10 Company Share Analysis
11.2. Market Concentration Rate
11.3. Intertek Group Plc.
- 11.3.1. Company Overview
- 11.3.2. Company Revenue
- 11.3.3. Products
- 11.3.4. Recent Developments
11.4. Avivia BV
- 11.4.1. Company Overview
- 11.4.2. Company Revenue
- 11.4.3. Products
- 11.4.4. Recent Developments
11.5. Almac Group
- 11.5.1. Company Overview
- 11.5.2. Company Revenue
- 11.5.3. Products
- 11.5.4. Recent Developments
11.6. Agilent Technologies Inc.
- 11.6.1. Company Overview
- 11.6.2. Company Revenue
- 11.6.3. Products
- 11.6.4. Recent Developments
11.7. Catalent Inc.
- 11.7.1. Company Overview
- 11.7.2. Company Revenue
- 11.7.3. Products
- 11.7.4. Recent Developments
11.8. Thermofisher Scientific Inc.
- 11.8.1. Company Overview
- 11.8.2. Company Revenue
- 11.8.3. Products
- 11.8.4. Recent Developments
11.9. Cambrex Corp
- 11.9.1. Company Overview
- 11.9.2. Company Revenue
- 11.9.3. Products
- 11.9.4. Recent Developments
11.10. Charles River Laboratories
- 11.10.1. Company Overview
- 11.10.2. Company Revenue
- 11.10.3. Products
- 11.10.4. Recent Developments
11.11. Boston Analytical
- 11.11.1. Company Overview
- 11.11.2. Company Revenue
- 11.11.3. Products
- 11.11.4. Recent Developments
11.12. Pace Analytical Life Sciences
- 11.12.1. Company Overview
- 11.12.2. Company Revenue
- 11.12.3. Products
- 11.12.4. Recent Developments
11.13. Sotax
- 11.13.1. Company Overview
- 11.13.2. Company Revenue
- 11.13.3. Products
- 11.13.4. Recent Developments
11.14. Amri
- 11.14.1. Company Overview
- 11.14.2. Company Revenue
- 11.14.3. Products
- 11.14.4. Recent Developments
11.15. SGS SA
- 11.15.1. Company Overview
- 11.15.2. Company Revenue
- 11.15.3. Products
- 11.15.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies